Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics in Monitoring Chronic Medication with Anti-Epileptic Drugs

  • Conference paper
Book cover Clinical Pharmacology of Anti-Epileptic Drugs

Abstract

Recognition that one acute dosage or regimen of dosages of anti-epileptic drugs can seldom predict a desired intensity, onset and/or duration of the therapeutic effect together with the progress in the analytical procedures to determine these drugs in body fluids have strongly stimulated the development of clinical pharmacokinetics. The availability of drug concentrations in body fluids has improved the possibility of monitoring patients on chronic medication. Clearance data calculated on collections of parameters (concentrations, dosage-interval and body weight or body surface) have opened the possibility to establish individual dosage regimens for a single drug or combination of drugs. To cure a disease, suppress (abnormal) physiological functions or support biochemical processes of an individual, a certain amount of one drug or a combination of drugs in the body will be required. The concentration reached in the biological environment where the pharmacological activity is thought to be located as well as in other areas of the body will depend on the regional physiological and physico-chemical characteristics of organs, tissues and their constituent elements. Flow of body fluids largely controls dispersion of drugs through the body. Diffusion controls the distribution of drugs in inadequately perfused body regions. Binding, generally considered an extremely rapid process, will largely control the ultimate regional, cellular and subcellular differences in concentration. The higher the affinity for extravascular, extra- or intracellular body constituents the lower the plasma concentration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashley, J. J., Levy, G.: Kinetics of diphenylhydantoin elimination in rat. J. Pharmacokinetics and Biopharmaceutics 1, 99 (1973).

    Article  CAS  Google Scholar 

  2. Atkinson, A. J., Shaw, J. M.: Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Clin. Pharmacol. Therap. 14, 521 (1973).

    Google Scholar 

  3. Augsberger, A.: Alte und neue Faustregeln für die Arzneidosierung bei Kindern. Triangel 5, 200 (Sandoz AG Nürnberg, 1962).

    Google Scholar 

  4. Blackwell, B.: Patient Compliance. New Engl. J. Med. 1973, 249.

    Google Scholar 

  5. Bochner, F., Hooper, W. D., Tyrer, J. H., Eadie, M. J.: Effect of dosage increments on blood phenytoin concentrations. J. Neurol. Neurosurg. Psychiat. 35, 873 (1972).

    Article  PubMed  CAS  Google Scholar 

  6. Buchanan, R. A., Fernandez, L., Kinkel, A. W.: Absorption and elimination of ethosuximide in children. J. clin. Pharmacol. 9, 393 (1969).

    CAS  Google Scholar 

  7. Buchthal, F., Lennox-Buchthal, M. A.: Phenobarbital: Relation of serum concentration to control of seizures. In: Anti-epileptic Drugs (Eds. D. M. Woodbury, J. K. Penry, R. P. Schmidt) 335. New York: Raven Press 1973.

    Google Scholar 

  8. Chang, Tsun, Glazko, A. J.: Diphenylhydantoin, Biotransformation. In: Anti-epileptic Drugs (Eds. D. M. Woodbury, J. K. Penry, R. P. Schmidt) 149. New York: Raven Press 1973.

    Google Scholar 

  9. Unit Dose Blister Packaging Machine. Amer. J. of Hosp. Pharm. April 1974.

    Google Scholar 

  10. Christiansen, J.: Assay of carbamazepine and metabolites in plasma by quantitative thin layer chromatography. In: Methods of analysis of anti-epileptic drugs (Eds. J. W. A. Meijer, H. Meinardi, C. Gardner-Thorpe, E. van der Kleijn), ICS 286, 187, Amsterdam: Excerpta Medica, New York: American Elsevier Co., Inc. 1973.

    Google Scholar 

  11. Dyton, P. G., Perel, J. M.: Physiological and Physicochemical Bases of drug interactions in man. Ann. N. Y. Acad. Sci. 179, 67 (1971).

    Article  Google Scholar 

  12. Dijkhuis, J. C., Ferguson, G. E. T.: Drooggevroren standaard serum en plasma voor antiepileptica bepalingen. Pharm. Weekbl. 109, 48 (1974).

    Google Scholar 

  13. Dijkhuis, I. C., Vervloet, E.: Rapid determination of the anti-epileptic drug di-n-propylacetic acid in serum. Pharm. Weekbl. 109, 42 (1974).

    CAS  Google Scholar 

  14. Glazko, A. J., Chang Tsun: Diphenylhydantoin: Absorption, distribution and excretion. In: Anti-epileptic Drugs (Eds. D. M. Woodbury, J. K. Penry, R. P. Schmidt) 127. New York: Raven Press 1973.

    Google Scholar 

  15. Dill, W. A., Peterson, L., Chang, T., Glazko, A. J.: Physiological disposition of methylethyl suximide in animals and man. Abstracts of Papers 149th Meeting ACS Detroit 1965, 30N.

    Google Scholar 

  16. Firemark, H., Barlow, C. F., Roth, L. J.: The entry accumulation and binding of diphenylhydantoin-2-14C in brain. Int. J. Neuropharmacol. 2, 25 (1963).

    Article  CAS  Google Scholar 

  17. Glazko, A. J., Chang, T., Baukema, J., Dill, W. A., Goulet, J. R., Buchanan, R. A.: Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration. Clin. Pharmacol. Ther. 10, 498 (1969).

    PubMed  CAS  Google Scholar 

  18. Green, J. R., Friel, P., Amick-Corkill, J. A.: Methods for gas liquid chromatography determinations of carbamazepine, phenytoin, phenobarbitone and primidone. In: Methods of analysis of anti-epileptic drugs (Eds. J. W. A. Meijer, H. Meinardi, C. Gardner- Thorpe, E. van der Kleijn), ICS 286, 176, Amsterdam: Excerpta Medica, New York: American Elsevier Co., Inc. 1973.

    Google Scholar 

  19. Guelen, P. J. M., van der Kleijn, E., Woudstra, U.: Statistical evaluation of pharmacokinetic parameters of anti-epileptic drugs. In: Clinical Pharmacology of Anti-Epileptic Drugs (Eds. H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin), p. 2, Berlin-Heidelberg-New York: Springer 1975.

    Google Scholar 

  20. Hansen, J. M., Kristensen, M., Skovsted, L.: Sulthiame (Ospolot), an inhibitor of diphenylhydantoin metabolism. Epilepsia (Amst.) 9, 17 (1968).

    Article  CAS  Google Scholar 

  21. Hansen, J. M., Siersback-Nielsen, K., Skovsted, L.: Carbamazepine induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin. Pharmacol. Ther. 12, 539 (1971).

    PubMed  CAS  Google Scholar 

  22. Kaplan, S., Jack, S. M. L., Alexander, K., Weinfeld, R.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administration. J. Pharm. Sci. 62, 1789 (1973).

    Article  PubMed  CAS  Google Scholar 

  23. Knop, H., van der Kleijn, E., Edmonds, C. L.: Pharmacokinetics of clonazepam in man and laboratory animals. This volume p. 427.

    Google Scholar 

  24. Lindquist, N. G., Ullberg, S.: The melanin affinity of chloroquine and chlorpromazine studied by wholebody autoradiography. Acta Pharmacol. Toxicol. 31, suppl. II (1972).

    Google Scholar 

  25. Laubscher, R. A.: Fatal diphenylhydantoin poisoning, a case report. J. Amer. med. Ass. 198, 1120 (1966).

    Article  CAS  Google Scholar 

  26. Levy, G., Tsuchiya, T., Amsel, L. P.: Limited capacity for salicylphenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin. Pharmacol. Ther. 13, 258 (1972).

    PubMed  CAS  Google Scholar 

  27. Lundquist, F., Wolthers, H.: The kinetics of alcohol elimination in man. Acta pharmacol. (Kbh.) 14, 265 (1958).

    Article  CAS  Google Scholar 

  28. Mannering, G. J.: Biotransformation. In: Antiepileptic Drugs (eds. D. M. Woodbury, J. K. Penry, R. P. Sdimidt), p. 23. New York: Raven Press 1972.

    Google Scholar 

  29. Meijer, J. W. A.: Simultaneous quantitative determination of anti-epileptic drugs including carbamazepine, in body fluids. Epilepsia 12, 341 (1971).

    Article  PubMed  CAS  Google Scholar 

  30. Meijer, J. W. A., Meinardi, H., Gardner-Thorpe, C., van der Kleijn, E., editors: Methods of analysis of anti-epileptic drugs. ICS 286, Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  31. Meilink, J. H.: Fluorimetric assay of carbamazepine and its metabolites in blood. Pharm. Weekbl. 109, 22 (1974).

    CAS  Google Scholar 

  32. Meinardi, H.: Carbamazepine. In: Anti-epileptic Drugs (Eds. D. M. Woodbury, J. K. Penry, R. P. Schmidt) 487. New York: Raven Press 1973.

    Google Scholar 

  33. Morselli, P. L., Biandrate, P., Frigerio, A., Gerna, M., Tognoni, G.: Gas chromatographic determination of carbamazepine and carbamazepine-10,ll-epoxide in human body fluids. Methods of Analysis of Anti-epileptic Drugs (J. W. A. Meijer, H. Meinardi, C. Gardner- Thorpe, E. van der Kleijn), ICS 286, 169. Amsterdam: Excerpta Medica, New York: American Elsevier Co., Inc. 1973.

    Google Scholar 

  34. Morselli, P. L., Rizzo, M., Garattini, S.: Interactions between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann. N. Y. Acad. Sci. 179, 88 (1971).

    Article  PubMed  CAS  Google Scholar 

  35. Nakamura, K., Masuda, Y., Nakatsuji, K., Hiroka, T.: Comparative studies on the distribution and metabolic fate of diphenylhydantoin and 3-ethylcarbomyldiphenylhydantoin after chronic administration to dogs and cats. Naunyn Schmiedebergs Arch. Pharmacol. 254, 406 (1966).

    CAS  Google Scholar 

  36. Palmer, L., Bertilsson, L., Collste, P., Rawlins, M.: Quantitative determination of Carbamazepin in plasma by mass fragmentography. Clin. Pharmacol. 14, 827 (1973).

    CAS  Google Scholar 

  37. Schobben, F., van der Kleijn, E.: Determination of sodium di-n-propylacetate in plasma by gas-liquid chromatography. Pharm. Weekbl. 109, 1 (1974).

    Google Scholar 

  38. Schobben, F., van der Kleijn, E.: Pharmacokinetics of distribution and elimination of sodium di-n-propylacetate in mouse and dog. Pharm. Weekbl. 109, 33 (1974).

    CAS  Google Scholar 

  39. Schobben, F., Gabreels, A., van der Kleijn, E.: Pharmacokinetics of di-n-propylacetate in epileptic patients. Europ. J. clin. Pharmacol. 8, 97–105 (1975).

    Article  CAS  Google Scholar 

  40. Sherwin, A. L.: Anticonvulsant drugs in human epileptogenic brain. Arch. Neurol. 29, 73 (1973).

    Article  PubMed  CAS  Google Scholar 

  41. Shirkey, H. C.: Pediatric Dosage Handbook. Amer. Pharm. Ass. 1973.

    Google Scholar 

  42. Sjöqvist, F., Alexanderson, B.: Drug interactions: a critical look at their documentation and clinical importance. Excerpta med. Internat. Congr. Scr. 254, 167 (1972).

    Google Scholar 

  43. Solomon, H. M., Schrogie, J. J.: The effect of phenyramidol on the metabolism of diphenylhydantoin. Clin. Pharmacol. Ther. 8, 554 (1967).

    PubMed  CAS  Google Scholar 

  44. Suzuki, T., Saitoh, J., Nishihara, K.: Kinetics of diphenylhydantoin disposition in man. Chem. Pharm. Bull. 18, 405 (1970).

    Article  PubMed  CAS  Google Scholar 

  45. Tigelaar, R. E., Rapport, R. L., Inman, J. K., Kupferberg, H. J.: A radio-immuno assay for diphenylhydantoin. Clin. Chim. Acta 43, 231 (1973).

    Article  PubMed  CAS  Google Scholar 

  46. Tyrer, J. H., Eadie, M. J., Sutherland, J. M., Hooper, W. D.: Outbreak of anticonvulsant intoxication in an Australian city. Brit. Med. J. 1970 IV, 271.

    Article  Google Scholar 

  47. van der Kleijn, E.: Kinetics of general and regional brain distribution of closely related 7-chloro-l,4-benzodiazepines. Benzodiazepines, p. 145. New York: Raven Press 1973.

    Google Scholar 

  48. van der Kleijn, E., Collste, P., Norlander, B., Agurell, S., Sjöqvist, F.: Gas chromatographic determination of ethosuximide and phensuximide in plasma and urine of man. J. Pharm. Pharmacol. 25, 324 (1973).

    Article  PubMed  Google Scholar 

  49. van der Kleijn, E., Pijnappel, H., van Wijk, C., Guelen, P., Rijntjes, N.: Pharmacokinetic concepts for chronic treatment with anti-epileptic drugs. In: Methods of Analysis of anti-epileptic drugs. (Eds. J. W. A. Meijer, H. Meinardi, C. Gardner-Thorpe, E. van der Kleijn), ICS 286, 9, Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  50. van der Pol, W. S., Deeleman, R., van der Kleijn, E., Lauw, M., Schönefeld, H., van Rossum, J. M., Crul, J. F.: Linear and non-linear pharmacokinetics of 4-hydroxybutyrate in humans. J. Pharmacokinetics and Biopharmaceutics, submitted for publication.

    Google Scholar 

  51. van Ginneken, C. A. M., van Rossum, J. M., Fleuren, H. L. J. M.: Linear and non-linear kinetics of drug elimination. J. Pharmacokinetics and Biopharmaceutics, Vol. II, 5, 395 to 415 (1974).

    Article  Google Scholar 

  52. Vree, T. B., Henderson, P. Th., van Rossum, J. M., Doukas, P. H.: In vivo and in vitro inhibition of the metabolism of N-alkyl substituted amphetamines in rat by ferrocenylisopropylamine. Xenobiotica 3, 23 (1973).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Sint Radboud Hospital, University of Nijmegen, Nijmegen, The Netherlands

    E. van der Kleijn, P. J. M. Guelen, C. van Wijk & I. Baars

Authors
  1. E. van der Kleijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. J. M. Guelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. van Wijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Baars
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurophysiol. Abtlg., Ges. f. Epilepsie-Fschg. e. V., 48 Bielefeld 13, Bethel, Maraweg 13, Germany

    H. Schneider

  2. Abteilung für Neurologie im Klinikum Charlottenburg, Freien Universität Berlin, Spandauer Damm 130, D-l, Berlin 19 (West), Germany

    D. Janz

  3. Exeter & Mid-Devon Hospitals, Royal Devon & Exeter Hospitals (Wonford), Barrack Road, EX2 5DW, Exeter, England

    C. Gardner-Thorpe M. D.

  4. Instituut voor Epilepsiebestrijding, Achterweg 5, Heemstede, The Netherlands

    H. Meinardi Ph. D.

  5. Montreal Neurological Institute, 3801 University Street, Montreal 112, Quebec, Canada

    A. L. Sherwin Ph. D.

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Springer-Verlag Berlin-Heidelberg

About this paper

Cite this paper

van der Kleijn, E., Guelen, P.J.M., van Wijk, C., Baars, I. (1975). Clinical Pharmacokinetics in Monitoring Chronic Medication with Anti-Epileptic Drugs. In: Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H., Sherwin, A.L. (eds) Clinical Pharmacology of Anti-Epileptic Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85921-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85921-2_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85923-6

  • Online ISBN: 978-3-642-85921-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation